简体中文
|
繁體中文
|
English
Business Wire Global sites
Business Wire Global
UK/Ireland
Deutschland
France
Italy
Japan
Home
News
Events
Media Services
About Us
Contact Us
Health and Pharmaceutical Press Releases
2024-08-28 16:56
Lubrizol Opens Beauty Research Institute in Shanghai, China
2024-08-26 11:06
European Commission approves Celltrion’s SteQeyma® (CT-P43), a biosimilar to Stelara® (ustekinumab), for the treatment of multiple chronic inflammatory diseases
2024-08-26 11:02
HemoHim's Global Market Success Rooted in Rigorous Quality Control
2024-08-23 13:11
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
2024-08-22 08:24
Innovo Therapeutics Inc. Announces Phase 2 Clinical Results Demonstrating the Innovative Efficacy of INV-001 for the Treatment of Post-thyroidectomy Scars
2024-08-21 10:47
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
2024-08-20 11:35
Guard Medical Announces FDA 510(k) Clearance for Additional Large Sizes of Its Novel NPseal® NPWT Surgical Dressing, Unlocking the Orthopedic Market
2024-08-13 13:08
Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis
2024-08-09 15:17
Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods
2024-08-09 14:40
Nichi BRITE Beta glucan as an onco-nutrition supplement in pancreatic cancer; Encouraging clinical results reported by Chikamori Hospital, Japan.
2024-08-09 13:03
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
2024-08-08 16:24
Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia
2024-08-08 10:11
Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2024-08-05 13:47
Galderma to pursue a new scientific partnership with L’Oréal to further advance its category leadership in dermatology
2024-08-01 14:15
Takeda Announces First Quarter FY2024 Results - Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
2024-08-01 14:10
Boston Oncology and King Fahd Medical City (KFMC) Partner to Advance Localized Cell & Gene Therapy in Saudi Arabia
2024-08-01 12:43
In-Depth Report on Global Oesophageal Cancer Clinical Trials Now Available
2024-08-01 11:51
Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program
2024-07-31 14:00
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
2024-07-31 13:43
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
<< First
< Previous
10
11
12
13
14
15
16
17
18
19
Next >
Last >>
57552
57529
57528
57525
57514
57506
57500
57470
57458
57455
57452
57448
57439
57409
57397
57396
57393
57391
57383
57382
Business Wire Weibo
Press Releases
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2025-04-25 15:55
Mantle Index Four (MI4) Fund Launches with Securitize as Tokenization Partner and Mantle Treasury as Anchor Investor
2025-04-25 15:50
Boomi World 2025: Accelerating What’s Next in AI, Integration, and the Connected Enterprise
2025-04-25 15:42
UPS to Acquire Andlauer Healthcare Group for $1.6 Billion, Strengthening its Global Offerings in Complex Healthcare Logistics
2025-04-25 15:39
Diligent Unveils AI Risk Essentials to Accelerate Risk Management and Elevate Governance
2025-04-25 11:57
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea